The increased BMI of the NAFLD-HCC group may increase the risk of malignancy by placing the body into a chronic inflammatory state via the release of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-α) [17]. Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.